Pamicell Stock Price at 19,450 Won... Up 0.26% from Previous Day

Pamisell has ranked among the top searched stocks for 7 days in the past month.

As of 10:30 AM on the 18th, Pamisell is trading at 19,450 KRW, up 0.26% from the previous day. This is a 10.98% decrease compared to December 3. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreigners are tentatively recorded as net sellers of 169,000 shares. Over the past 5 days, individual investors have net sold 123,186 shares, while foreigners and institutions have net bought 62,895 shares and 25,764 shares, respectively.

On December 17, Pamisell became an issue in the market with the headline 'Stem cell therapy "unauthorized freezing" suspicion... stock price decline.'

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.